BioXcel Therapeutics CEO Vimal Mehta's 2022 pay falls 51% to $4.6M
BioXcel Therapeutics reports 2022 executive compensation
By ExecPay News
Published: May 17, 2023
BioXcel Therapeutics reported fiscal year 2022 executive compensation information on May 17, 2023.
In 2022, three executives at BioXcel Therapeutics received on average a compensation package of $2.6M, a 29% decrease compared to previous year.
Average pay of disclosed executives at BioXcel Therapeutics
Vimal Mehta, Chief Executive Officer, received $4.6M in total, which decreased by 51% compared to 2021. 44% of Mehta's compensation, or $2M, was in option awards. Mehta also received $150K in bonus, $655K in non-equity incentive plan, $944K in salary, $801K in stock awards, as well as $15K in other compensation.
Matthew Wiley, SVP and Chief Commercial Officer, received a compensation package of $1.9M. 68% of the compensation package, or $1.3M, was in option awards.
Javier Rodriguez, Chief Legal Officer, earned $1.2M in 2022, a 40% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on May 17, 2023.